CIGNA INVESTMENTS INC /NEW - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIGNA INVESTMENTS INC /NEW ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$387,000
-31.4%
2,851
-16.7%
0.03%
-26.7%
Q3 2018$564,000
-1.1%
3,424
+24.3%
0.04%
+9.8%
Q2 2018$570,0002,7540.04%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders